Bioxcel therapeutics to present at the 2021 jefferies london healthcare conference

New haven, conn., nov. 11, 2021 (globe newswire) -- bioxcel therapeutics, inc. (nasdaq: btai), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced that vimal mehta, ph.d., founder and chief executive officer, and frank yocca, ph.d., chief scientific officer , will participate in a fireside chat at the 12th annual jefferies global healthcare conference in london on wednesday, november 17, 2021 at 4:20 p.m. gmt / 11:20 a.m. et. dr. mehta and dr. yocca will highlight the company's neuroscience and immune-oncology programs, artificial intelligence platform used to augment and accelerate the drug candidate discovery and development process, and its commercial and launch readiness plans for bxcl501.
BTAI Ratings Summary
BTAI Quant Ranking